 effect town live viru vaccin cytomegaloviru diseas renal transplant control trial object efficaci vaccin town cytomegaloviru vaccin design double-blind placebo-control trial candid renal transplant cytomegaloviru serolog statu recipi donor recipi period month year transplant set univers transplant center patient analys patient vaccin placebo renal transplant month intervent subcutan inocul town viru placebo main outcom measur presenc cytomegaloviru infect viru isol antibodi test infect score system cytomegaloviru diseas diseas sever result vaccin discern long-term advers effect recipi seroposit vaccin protect efficaci group risk cytomegaloviru diseas recipi seroneg time vaccin kidney seroposit donor placebo recipi patient group sever cytomegaloviru diseas signific reduct diseas score decreas sever diseas CI infect rate similar graft surviv month vaccin recipi cadav kidney unvaccin recipi conclus previou vaccin seroneg renal transplant recipi live cytomegaloviru result reduct diseas sever action immun